Conditional cash transfers to retain rural Kenyan women in the continuum of care during pregnancy, birth and the postnatal period: protocol for a cluster randomized controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 19 03 2018
accepted: 28 01 2019
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 27 6 2019
Statut: epublish

Résumé

Antenatal care (ANC), facility delivery and postnatal care (PNC) are proven to reduce maternal and child mortality and morbidity in high-burden settings. However, few pregnant rural women use these services sufficiently. This study aims to assess the impact, cost-effectiveness and scalability of conditional cash transfers to promote increased contact between pregnant women or women who have recently given birth and the formal healthcare system in Kenya. The intervention tested is a conditional cash transfer to women for ANC health visits, a facility birth and PNC visits until their newborn baby reaches 1 year of age. The study is a cluster randomized controlled trial in Siaya County, Kenya. The trial clusters are 48 randomly selected public primary health facilities, 24 of which are in the intervention arm of the study and 24 in the control arm. The unit of randomization is the health facility. A target sample of 7200 study participants comprises pregnant women identified and recruited at their first ANC visit over a 12-month recruitment period and their subsequent newborns. All pregnant women attending one of the selected trial facilities for their first ANC visit during the recruitment period are eligible for the trial and invited to participate. Enrolled mothers are followed up at all health visits during their pregnancy, at facility delivery and for a number of visits after delivery. They are also contacted at three additional time points after enrolling in the study: 5-10days after enrolment, 6 months after the expected delivery date and 12 27 months after birth. If they have not delivered in a facility, there is an additional follow-up 2 wees after the expected due date. The impact of the conditional cash transfers on maternal healthcare services and utilization will be measured by the trial's primary outcomes: the proportion of all eligible ANC visits made during pregnancy, delivery at a health facility, the proportion of all eligible PNC visits attended, the proportion of referrals attended during the pregnancy and the postnatal period, and the proportion of eligible child immunization appointments attended. Secondary outcomes include; health screening and infection control, live birth, maternal and child survival 48 h after delivery, exclusive breastfeeding, post-partum contraceptive use and maternal and newborn morbidity. Data sources for the measurement of outcomes include routine health records, an electronic card-reader system and telephone surveys and focus group discussions. A full economic evaluation will be conducted to assess the cost of delivery and cost effectiveness of the intervention and the benefit incidence and equity impact of trial activities and outcomes. This trial will contribute to evidence on the effectiveness and cost-effectiveness of conditional cash transfers in facilitating health visits and promoting maternal and child health in rural Kenya and in other comparable contexts. ClinicalTrials.gov, NCT03021070 . Registered on 13 January 2017.

Sections du résumé

BACKGROUND BACKGROUND
Antenatal care (ANC), facility delivery and postnatal care (PNC) are proven to reduce maternal and child mortality and morbidity in high-burden settings. However, few pregnant rural women use these services sufficiently. This study aims to assess the impact, cost-effectiveness and scalability of conditional cash transfers to promote increased contact between pregnant women or women who have recently given birth and the formal healthcare system in Kenya.
METHODS METHODS
The intervention tested is a conditional cash transfer to women for ANC health visits, a facility birth and PNC visits until their newborn baby reaches 1 year of age. The study is a cluster randomized controlled trial in Siaya County, Kenya. The trial clusters are 48 randomly selected public primary health facilities, 24 of which are in the intervention arm of the study and 24 in the control arm. The unit of randomization is the health facility. A target sample of 7200 study participants comprises pregnant women identified and recruited at their first ANC visit over a 12-month recruitment period and their subsequent newborns. All pregnant women attending one of the selected trial facilities for their first ANC visit during the recruitment period are eligible for the trial and invited to participate. Enrolled mothers are followed up at all health visits during their pregnancy, at facility delivery and for a number of visits after delivery. They are also contacted at three additional time points after enrolling in the study: 5-10days after enrolment, 6 months after the expected delivery date and 12 27 months after birth. If they have not delivered in a facility, there is an additional follow-up 2 wees after the expected due date. The impact of the conditional cash transfers on maternal healthcare services and utilization will be measured by the trial's primary outcomes: the proportion of all eligible ANC visits made during pregnancy, delivery at a health facility, the proportion of all eligible PNC visits attended, the proportion of referrals attended during the pregnancy and the postnatal period, and the proportion of eligible child immunization appointments attended. Secondary outcomes include; health screening and infection control, live birth, maternal and child survival 48 h after delivery, exclusive breastfeeding, post-partum contraceptive use and maternal and newborn morbidity. Data sources for the measurement of outcomes include routine health records, an electronic card-reader system and telephone surveys and focus group discussions. A full economic evaluation will be conducted to assess the cost of delivery and cost effectiveness of the intervention and the benefit incidence and equity impact of trial activities and outcomes.
DISCUSSION CONCLUSIONS
This trial will contribute to evidence on the effectiveness and cost-effectiveness of conditional cash transfers in facilitating health visits and promoting maternal and child health in rural Kenya and in other comparable contexts.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov, NCT03021070 . Registered on 13 January 2017.

Identifiants

pubmed: 30823886
doi: 10.1186/s13063-019-3224-8
pii: 10.1186/s13063-019-3224-8
pmc: PMC6397480
doi:

Banques de données

ClinicalTrials.gov
['NCT03021070']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152

Subventions

Organisme : Bill and Melinda Gates Foundation
ID : OPP1142564

Références

Aust N Z J Public Health. 1999 Jun;23(3):285-8
pubmed: 10388173
Soc Sci Med. 2003 Jul;57(2):355-74
pubmed: 12765714
Drug Alcohol Depend. 2003 Aug 20;71(2):127-31
pubmed: 12927650
Trop Doct. 1992 Oct;22(4):161-3
pubmed: 1440883
BMJ. 2004 Mar 20;328(7441):702-8
pubmed: 15031246
Lancet. 2005 Feb 19-25;365(9460):711-22
pubmed: 15721478
Cah Sociol Demogr Med. 2005 Jan-Mar;45(1):135-61
pubmed: 15938446
Psychiatr Serv. 2006 Mar;57(3):414-6
pubmed: 16525004
BMJ. 2009 Apr 09;338:b1415
pubmed: 19359291
Hum Resour Health. 2009 May 20;7:40
pubmed: 19457237
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
BMC Health Serv Res. 2013 Jan 04;13:6
pubmed: 23289547
Trials. 2013 Jan 12;14:15
pubmed: 23311722
PLoS One. 2013;8(1):e53747
pubmed: 23335973
BMC Health Serv Res. 2013 Jul 26;13:287
pubmed: 23890185
Reprod Health. 2013 Aug 20;10:40
pubmed: 23962135
PLoS One. 2014 Mar 11;9(3):e90347
pubmed: 24618584
Trials. 2014 Jul 05;15:267
pubmed: 24996765
Health Psychol Rev. 2014;8(3):286-95
pubmed: 25053215
J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S150-6
pubmed: 25310122
Trop Med Int Health. 2015 Jun;20(6):781-90
pubmed: 25707376
Afr J Reprod Health. 2015 Sep;19(3):144-50
pubmed: 26897923
BMC Health Serv Res. 2016 Jul 28;16:314
pubmed: 27464679
Am J Public Health. 1998 May;88(5):792-6
pubmed: 9585747

Auteurs

Caroline A Ochieng (CA)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Hassan Haghparast-Bidgoli (H)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Neha Batura (N)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Aloyce Odhiambo (A)

Safe Water and AIDS Project (SWAP), P.O. Box 3323, Kisumu, 40100, Kenya.

Geordan Shannon (G)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Andrew Copas (A)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Tom Palmer (T)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Sarah Dickin (S)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Stacey Noel (S)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Matthew Fielding (M)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Sangoro Onyango (S)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Sarah Odera (S)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden.

Alie Eleveld (A)

Safe Water and AIDS Project (SWAP), P.O. Box 3323, Kisumu, 40100, Kenya.

Alex Mwaki (A)

Safe Water and AIDS Project (SWAP), P.O. Box 3323, Kisumu, 40100, Kenya.

Fedra Vanhuyse (F)

Stockholm Environment Institute, Linnegatan 87D, Box 24218, 10451, Stockholm, Sweden. fedra.vanhuyse@sei.org.

Jolene Skordis (J)

UCL Institute for Global Health, 3rd floor, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH